New York, April 23, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Pharmerging Industry" - https://www.reportlinker.com/p05800059/?utm_source=GNW
5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$936.2 Million by the year 2025, Pharmaceutical will bring in healthy gains adding significant momentum to global growth.
- Representing the developed world, the United States will maintain a 12.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$35.7 Million to the region’s size and clout in the next 5 to 6 years. Over US$36.1 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Pharmaceutical will reach a market size of US$69.6 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 10.5% over the next couple of years and add approximately US$133.8 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
- Competitors identified in this market include, among others,
- Abbott Laboratories
- AbbVie, Inc.
- Alexion Pharmaceuticals, Inc.
- Allergan PLC
- Amgen, Inc.
- Aspen Pharmacare Holdings Ltd.
- Astellas Pharma, Inc.
- AstraZeneca PLC
- Baxter International, Inc.
- Bayer AG
- Biogen, Inc.
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Company
- Celgene Corporation
- CSL Behring
- Daiichi Sankyo Co., Ltd.
- Eisai Co., Ltd.
- Eli Lilly and Company
- Endo International PLC
- F. Hoffmann-La Roche AG
- GlaxoSmithKline PLC
- Grifols SA
- H. Lundbeck A/S
- Hospira, Inc.
- Johnson & Johnson
- Kyowa Hakko Kirin Co., Ltd.
- Mallinckrodt Pharmaceuticals
- Mitsubishi Tanabe Pharma Corporation
- Mylan Pharmaceutical Pvt. Ltd.
- Novartis AG
- Novo Nordisk A/S
- Otsuka Pharmaceutical Co., Ltd.
- Pfizer, Inc.
- Sanofi SA
- Shire PLC
- Stada Arzneimittel AG
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co., Ltd.
- Teva Pharmaceutical Industries Ltd.
- UCB SA
Read the full report: https://www.reportlinker.com/p05800059/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Pharmerging Market to Grow Steadily, Driven by Rapid Growth of
the Pharma Sector
Worldwide Pharmaceutical Market Growth Projections by Regional
Group: 2018 and 2022
Breakdown of Growth Percentage and Spending in Billion USD for
Pharmerging Markets by Country: 2007-2022
Global Competitor Market Shares
Pharmerging Competitor Market Share Scenario Worldwide (in %):
2019 & 2025
Pharmaceutical Segment to Register Strong Growth
Total Spending on Medicines (in Billion USD) in Select Emerging
Pharmaceutical Markets: 2023
Healthcare Market in Tier I Pharmerging Region (USD Billion) by
Product: 2014-2025
Asia-Pacific Region to Retain Top Slot
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Geriatric Population to Bode Well for Market Growth
Total Breakdown of People Aged Over 60 by Development Groups:
1980 to 2050
Increase in Patient Numbers to Support Market Growth
Top Therapeutic Areas by Spending (Billion USD) in Pharmerging
Markets: 2018
Select Therapy Areas Spending (Billion USD) in Pharmerging
Markets: 2020
Increasing Preference for Generics to Spur Market Expansion
4. GLOBAL MARKET PERSPECTIVE
Table 1: Pharmerging Global Market Estimates and Forecasts in
US$ Thousand by Region/Country: 2018-2025
Table 2: Pharmerging Market Share Shift across Key Geographies
Worldwide: 2019 VS 2025
Table 3: Pharmaceutical (Product) World Market by
Region/Country in US$ Thousand: 2018 to 2025
Table 4: Pharmaceutical (Product) Market Share Breakdown of
Worldwide Sales by Region/Country: 2019 VS 2025
Table 5: Healthcare (Product) Potential Growth Markets
Worldwide in US$ Thousand: 2018 to 2025
Table 6: Healthcare (Product) Market Sales Breakdown by
Region/Country in Percentage: 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Pharmerging Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 7: United States Pharmerging Market Estimates and
Projections in US$ Thousand by Product: 2018 to 2025
Table 8: United States Pharmerging Market Share Breakdown by
Product: 2019 VS 2025
CANADA
Table 9: Canadian Pharmerging Market Estimates and Forecasts in
US$ Thousand by Product: 2018 to 2025
Table 10: Pharmerging Market in Canada: Percentage Share
Breakdown of Sales by Product for 2019 and 2025
JAPAN
Table 11: Japanese Market for Pharmerging: Annual Sales
Estimates and Projections in US$ Thousand by Product for the
Period 2018-2025
Table 12: Japanese Pharmerging Market Share Analysis by
Product: 2019 VS 2025
CHINA
Table 13: Chinese Pharmerging Market Growth Prospects in US$
Thousand by Product for the Period 2018-2025
Table 14: Chinese Pharmerging Market by Product: Percentage
Breakdown of Sales for 2019 and 2025
EUROPE
Market Facts & Figures
European Pharmerging Market: Competitor Market Share Scenario
(in %) for 2019 & 2025
Market Analytics
Table 15: European Pharmerging Market Demand Scenario in US$
Thousand by Region/Country: 2018-2025
Table 16: European Pharmerging Market Share Shift by
Region/Country: 2019 VS 2025
Table 17: European Pharmerging Market Estimates and Forecasts
in US$ Thousand by Product: 2018-2025
Table 18: European Pharmerging Market Share Breakdown by
Product: 2019 VS 2025
FRANCE
Table 19: Pharmerging Market in France by Product: Estimates
and Projections in US$ Thousand for the Period 2018-2025
Table 20: French Pharmerging Market Share Analysis by Product:
2019 VS 2025
GERMANY
Table 21: Pharmerging Market in Germany: Recent Past, Current
and Future Analysis in US$ Thousand by Product for the Period
2018-2025
Table 22: German Pharmerging Market Share Breakdown by Product:
2019 VS 2025
ITALY
Table 23: Italian Pharmerging Market Growth Prospects in US$
Thousand by Product for the Period 2018-2025
Table 24: Italian Pharmerging Market by Product: Percentage
Breakdown of Sales for 2019 and 2025
UNITED KINGDOM
Table 25: United Kingdom Market for Pharmerging: Annual Sales
Estimates and Projections in US$ Thousand by Product for the
Period 2018-2025
Table 26: United Kingdom Pharmerging Market Share Analysis by
Product: 2019 VS 2025
REST OF EUROPE
Table 27: Rest of Europe Pharmerging Market Estimates and
Forecasts in US$ Thousand by Product: 2018-2025
Table 28: Rest of Europe Pharmerging Market Share Breakdown by
Product: 2019 VS 2025
ASIA-PACIFIC
Table 29: Pharmerging Market in Asia-Pacific by Product:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 30: Asia-Pacific Pharmerging Market Share Analysis by
Product: 2019 VS 2025
REST OF WORLD
Table 31: Rest of World Pharmerging Market Estimates and
Forecasts in US$ Thousand by Product: 2018 to 2025
Table 32: Pharmerging Market in Rest of World: Percentage Share
Breakdown of Sales by Product for 2019 and 2025
IV. COMPETITION
ABBOTT LABORATORIES
ABBVIE
ALEXION PHARMACEUTICALS
ALLERGAN PLC
ASPEN PHARMACARE HOLDINGS
ASTELLAS PHARMA
ASTRAZENECA PLC
BAXTER INTERNATIONAL
BAYER AG
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL-MYERS SQUIBB COMPANY
CSL BEHRING
CELGENE CORPORATION
DAIICHI SANKYO
EISAI CO., LTD.
ELI LILLY AND COMPANY
ENDO INTERNATIONAL PLC
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
GRIFOLS SA
H. LUNDBECK A/S
HOSPIRA
JOHNSON & JOHNSON
MITSUBISHI TANABE PHARMA CORPORATION
MYLAN PHARMACEUTICAL PVT.
NOVARTIS AG
NOVO NORDISK A/S
OTSUKA PHARMACEUTICAL
PFIZER
STADA ARZNEIMITTEL AG
SANOFI SA
SHIRE PLC
SUN PHARMACEUTICAL INDUSTRIES
TAKEDA PHARMACEUTICAL COMPANY LIMITED
TEVA PHARMACEUTICAL INDUSTRIES
UCB SA
KYOWA HAKKO KIRIN
V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05800059/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________